Pharma IQ Members

Bioreactor

A Bioreactor is defined as a closed system used for bioprocessing (flask, roller bottle, tank, vessel, or other container), which supports the growth of cells, mammalian or bacterial, in a culture medium. A bacterial reaction usually is said to take place in a fermenter, and cell culture in a bioreactor.

11 results
of 2
Biotech thumb

Biotech sees swift growth in job openings despite the shrinking level of life sciences vacancies

The amount of new job openings in biotech increased by more than a third in the year to August 2017, according to the Association of...

Contributor: Pharma IQ
Tags:
Wed, 10/18/2017
dispos

The need for more speed to the market in biomanufacturing is fueling the acceptance and implementation of single use systems despite their complications

• Over 60% of respondents can see biomanufacturing sites becoming 100% disposable one...

Contributor: Pharma IQ
Tags:
Wed, 09/20/2017
bio via wp

It is no secret that Life Science manufacturers have substantial compliance challenges. Regulatory burdens are getting more intense, regularly changing, and growing in complexity. This is most keenly felt by those that are delivering products in...

Contributor: Dan Jacob
Mon, 09/11/2017
C&G

The international regenerative medicines market – which includes the likes of cell therapies, gene/gene-modified cell therapy and tissue engineering – is set to climb to around $67 billion by 2020.  Alongside, discovering therapies that will...

Contributor: Pharma IQ
Tags:
Tue, 05/23/2017
biomanufacturing, drug manufacturing, drug production
Contributor: Pharma IQ
Tags:
Tue, 05/16/2017
Heatmap
The Road To Commercialisation with Cell and Gene Therapies

Over the last 12 months, the cell and gene therapy manufacturing sphere has matured vastly with more companies advancing to commercial products, especially with allogenic therapies. Now...

Contributor: Pharma IQ
Tags:
Tue, 04/25/2017
Pharma IQ News
Strong Growth is expected in the Overall Upstream Process marketUpstream process is vital in the manufacturing of biopharmaceuticals to have control over growth conditions and nutrients which eventually reflects in an increased overall yield. GBI...
Contributor: Pharma IQ News
Tue, 02/07/2012
Eric Langer

Single use technologies are strong change agents in biopharma manufacturing.  Disposable devices emerge once again as a top new technology of interest among the 352 surveyed biomanufacturers in BioPlan Associates, Inc.’s 2011 8th Annual Report...

Contributor: Eric Langer
Mon, 08/08/2011
11 results
of 2